Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78622639 | 7862263 | 9 | F | 20101116 | 20160919 | 20110318 | 20160920 | EXP | CA-ROCHE-764891 | ROCHE | 56.00 | YR | M | Y | 70.37000 | KG | 20160921 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78622639 | 7862263 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | U | 125276 | 608 | MG | SOLUTION FOR INFUSION | ||||||
| 78622639 | 7862263 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | LAST DOSE: 05/SEPT/2013 | Y | U | 125276 | SOLUTION FOR INFUSION | |||||||
| 78622639 | 7862263 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | U | 125276 | 560 | MG | SOLUTION FOR INFUSION | ||||||
| 78622639 | 7862263 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Subcutaneous | D | 125472 | 162 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||
| 78622639 | 7862263 | 5 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 78622639 | 7862263 | 6 | C | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | 0 | ||||||||||||
| 78622639 | 7862263 | 7 | C | TYLENOL WITH CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Unknown | PRN (AS NECESSARY) | 0 | ||||||||||
| 78622639 | 7862263 | 8 | C | ACTONEL | RISEDRONATE SODIUM | 1 | 0 | ||||||||||||
| 78622639 | 7862263 | 9 | C | AVALIDE | HYDROCHLOROTHIAZIDEIRBESARTAN | 1 | 0 | ||||||||||||
| 78622639 | 7862263 | 10 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | 0 | ||||||||||||
| 78622639 | 7862263 | 11 | C | RANITIDINE. | RANITIDINE | 1 | 0 | ||||||||||||
| 78622639 | 7862263 | 12 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 78622639 | 7862263 | 1 | Rheumatoid arthritis |
| 78622639 | 7862263 | 4 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 78622639 | 7862263 | HO |
| 78622639 | 7862263 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 78622639 | 7862263 | Blood pressure increased | |
| 78622639 | 7862263 | Drug ineffective | |
| 78622639 | 7862263 | Hypertension | |
| 78622639 | 7862263 | Infection | |
| 78622639 | 7862263 | Pain | |
| 78622639 | 7862263 | Stress | |
| 78622639 | 7862263 | Tenoplasty | |
| 78622639 | 7862263 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 78622639 | 7862263 | 1 | 20101103 | 201507 | 0 | |
| 78622639 | 7862263 | 4 | 20150901 | 0 |